Literature DB >> 22581930

"Undiagnosing" multiple sclerosis: the challenge of misdiagnosis in MS.

Andrew J Solomon1, Eran P Klein, Dennis Bourdette.   

Abstract

OBJECTIVE: To describe the clinical characteristics of encounters with patients misdiagnosed with multiple sclerosis (MS).
METHODS: A cross-sectional Internet-based physician survey of MS specialists was performed.
RESULTS: The response rate for the survey was 50.4%. Of those who responded, the majority (95%) reported having evaluated 1 or more patients who had been diagnosed with MS, but who they strongly felt did not have MS, within the last year. The majority of respondents (>90%) also reported the use of disease-modifying therapy in a proportion of these patients. Most respondents (94%) found clinical encounters with these patients equally or more challenging than giving a new diagnosis of MS. Fourteen percent of respondents reported that they did not always inform such patients of their opinion that they did not have MS.
CONCLUSIONS: The misdiagnosis of MS is common and has significant consequences for patient care and health care system costs. Caring for a patient with a misdiagnosis of MS is challenging, and at times honest disclosure of a misdiagnosis represents an important ethical concern for neurologists. More data are needed on this patient population to improve diagnostic acumen and the care of these patients.

Entities:  

Mesh:

Year:  2012        PMID: 22581930      PMCID: PMC3369504          DOI: 10.1212/WNL.0b013e318259e1b2

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

Review 1.  The radiologically isolated syndrome: look (again) before you treat.

Authors:  Rebecca Spain; Dennis Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

Review 2.  Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.

Authors:  David Bates
Journal:  Neurology       Date:  2011-01-04       Impact factor: 9.910

3.  Pseudo-multiple sclerosis.

Authors:  G W Paulson
Journal:  South Med J       Date:  1996-03       Impact factor: 0.954

4.  Differential diagnosis of suspected multiple sclerosis: a consensus approach.

Authors:  D H Miller; B G Weinshenker; M Filippi; B L Banwell; J A Cohen; M S Freedman; S L Galetta; M Hutchinson; R T Johnson; L Kappos; J Kira; F D Lublin; H F McFarland; X Montalban; H Panitch; J R Richert; S C Reingold; C H Polman
Journal:  Mult Scler       Date:  2008-09-19       Impact factor: 6.312

5.  Early treatment of multiple sclerosis to prevent neurologic damage.

Authors:  Patricia K Coyle
Journal:  Neurology       Date:  2008-12-09       Impact factor: 9.910

Review 6.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

7.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

  7 in total
  35 in total

Review 1.  Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention.

Authors:  Andrew J Solomon; Brian G Weinshenker
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

2.  Dark Rims: Novel Sequence Enhances Diagnostic Specificity in Multiple Sclerosis.

Authors:  J-M Tillema; S D Weigand; M Dayan; Y Shu; O H Kantarci; C F Lucchinetti; J D Port
Journal:  AJNR Am J Neuroradiol       Date:  2018-04-26       Impact factor: 3.825

3.  Automated Integration of Multimodal MRI for the Probabilistic Detection of the Central Vein Sign in White Matter Lesions.

Authors:  J D Dworkin; P Sati; A Solomon; D L Pham; R Watts; M L Martin; D Ontaneda; M K Schindler; D S Reich; R T Shinohara
Journal:  AJNR Am J Neuroradiol       Date:  2018-09-13       Impact factor: 3.825

Review 4.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

Review 5.  The tension between early diagnosis and misdiagnosis of multiple sclerosis.

Authors:  Andrew J Solomon; John R Corboy
Journal:  Nat Rev Neurol       Date:  2017-08-11       Impact factor: 42.937

Review 6.  Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice.

Authors:  Andrew J Solomon; Robert T Naismith; Anne H Cross
Journal:  Neurology       Date:  2018-10-31       Impact factor: 9.910

Review 7.  Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.

Authors:  James D Weisfeld-Adams; Ilana B Katz Sand; Justin M Honce; Fred D Lublin
Journal:  Brain       Date:  2015-01-29       Impact factor: 13.501

8.  Improving outcomes in multiple sclerosis through early diagnosis and effective management.

Authors:  Emmanuelle Waubant
Journal:  Prim Care Companion CNS Disord       Date:  2012-10-25

9.  Multiple sclerosis: Oligoclonal bands--a useful tool to avoid MS misdiagnosis.

Authors:  José C Álvarez-Cermeño; Luisa M Villar
Journal:  Nat Rev Neurol       Date:  2013-04-16       Impact factor: 42.937

10.  Reducing costs while enhancing quality of care in MS.

Authors:  Ilya Kister; John R Corboy
Journal:  Neurology       Date:  2016-09-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.